Surgepays is trading $0.16 (-5.43%) after no new company-specific announcement was identified for August 25, 2026, leaving the immediate catalyst unclear.
- Recent selling followed the August 19, 2026 filing showing $1.95 million in cash and a $21.3 million working-capital deficit.
- Management also raised substantial doubt about continuing operations.
- Broader markets are higher, limiting support for a market-wide explanation.